SPX3,963.51+29.59 0.75%
DIA338.46+2.02 0.60%
IXIC11,082.00+123.45 1.13%

Citigroup Maintains Neutral on Bright Health Gr, Lowers Price Target to $1.2

Benzinga · 11/16/2022 07:44
Citigroup analyst Jason Cassorla maintains Bright Health Gr (NYSE:BHG) with a Neutral and lowers the price target from $2.25 to $1.2.